♦ Receipt and communication as appropriate of safety information resulting
from analyses by UMC and from regulatory agencies, case reports and the
literature
♦ Provision of feedback to reporters
♦ Timely advice to health-care professionals and consumers on drug safety
issues
♦ Education and training
♦ Information sharing at regional and global levels.